A Metastatic Pulmonary Sarcomatoid Carcinoma Patient Harboring KIF5B-RET Fusion Responds to First-Line Pralsetinib Treatment: A Case Report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer (NSCLC), accounting for about 1% of cases. These tumors are characterized by their high malignancy and frequent resistance to chemotherapy, resulting in a worse prognosis compared to other NSCLC subtypes. Currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hao, Wan, Yuxiang, Dong, Yuchao, Sun, Qinying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387260/
https://www.ncbi.nlm.nih.gov/pubmed/37525669
http://dx.doi.org/10.2147/CMAR.S414077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387260/
https://www.ncbi.nlm.nih.gov/pubmed/37525669
http://dx.doi.org/10.2147/CMAR.S414077

Ejemplares similares